Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/14/2000WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation
12/14/2000WO2000047716A3 Fibres for culturing eukaryotic cells
12/14/2000WO2000047284A3 Novel use of orexin receptor antagonists
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000047217A3 Protection of cells in connection with treatment with chemical agents
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000044408A3 Method of treating demyelinating inflammatory disease using ccr1 antagonists
12/14/2000WO2000044399A3 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
12/14/2000WO2000044393A3 Buccal delivery system for proteinaceous medicaments
12/14/2000WO2000044348A3 Materials and methods for making improved micelle compositions
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
12/14/2000WO2000010589A9 Somatostatin analogs
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926620A1 Neue Cycloiminodepsipeptide, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Endoparasiten New Cycloiminodepsipeptide, processes for their preparation and their use for controlling endoparasites
12/14/2000DE19926554A1 Pulmonary surfactant preparation for treatment or prophylaxis of infant or adult respiratory distress syndrome or acute lung injury, containing modifications of surfactant proteins B and C
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000CA2390090A1 Peptides
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2377385A1 Methods and compositions for modulating cell proliferation and cell death
12/14/2000CA2376939A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000CA2376729A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000CA2376663A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376490A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376358A1 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376175A1 Vitamin directed dual targeting therapy
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375914A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375874A1 Use of riluzole for the treatment of multiple sclerosis
12/14/2000CA2375627A1 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
12/14/2000CA2375617A1 Targeted angiogenesis
12/14/2000CA2375602A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000CA2375424A1 Novel polynucleotides and polypeptides encoded thereby
12/14/2000CA2375148A1 Compositions for the treatment of the catabolic state of prolonged critical illness
12/14/2000CA2375145A1 Substrate trapping protein tyrosine phosphatases
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2373356A1 Detection of ryanodine receptor antibodies
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2345030A1 Composition and method for the treatment of endotoxic shock and inflammatory and autoimmune diseases in mammals
12/14/2000CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/13/2000EP1059353A2 Novel calpain and dna encoding the same
12/13/2000EP1059303A2 Process for dissolution of albumin flakes in a solvent and apparatus for process
12/13/2000EP1059302A1 Factor VIIa inhibitors
12/13/2000EP1059089A1 Preventives/remedies for inflammatory intestinal disease
12/13/2000EP1059041A1 The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058734A2 Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities
12/13/2000EP1058730A1 Human synapse related glycoproteins (hsrp)
12/13/2000EP1058729A1 Smad binding elements and uses thereof
12/13/2000EP1058728A1 V-like domain binding molecules
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058725A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058690A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/13/2000EP1058689A1 Alpha-ketoamide inhibitors of 20s proteasome
12/13/2000EP1058562A1 Compositions and methods of treating tumors
12/13/2000EP1058560A1 Topical ophthalmic preparations containing immunosuppressive agents
12/13/2000EP1058557A1 Enhancement of immunity by intranasal inoculation of il-12
12/13/2000EP1058556A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
12/13/2000EP1058555A1 Costimulatory blockade and mixed chimerism in allotransplantation
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP1058539A1 Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0927196A4 Polymers containing polysaccharides such as alginates or modified alginates
12/13/2000EP0914144B1 Therapeutic uses of bpi protein products for human meningococcemia
12/13/2000EP0802784B1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
12/13/2000EP0681491B1 Intrapulmonary delivery of hormones
12/13/2000EP0680334B1 Morphogen treatment of gastrointestinal ulcers
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276796A Biomolecules comprising elastomeric peptide
12/13/2000CN1276794A Triplex forming oligonucleotides and their use in anti-HBV
12/13/2000CN1276732A Composition for controlling bacterial colonization
12/13/2000CN1276731A Insoluble insulin compositions
12/13/2000CN1276730A Use of IFN-alpha and amantadine for treatment of chronic hepatitis C
12/13/2000CN1276729A Heparin-binding growth factor (HBGF) polypeptides
12/13/2000CN1276728A Therapy for staphylococcus aureus
12/13/2000CN1276727A Growth hormone secretagogues
12/13/2000CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency
12/13/2000CN1276725A Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma
12/13/2000CN1276382A Process for preparing recombined human thrombopoietin preparation
12/13/2000CN1276381A Application of growth factor neuregulin and its analogs
1 ... 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 ... 3163